Timothy A - Search Results

1

Hypofractionated radiotherapy for invasive bladder cancer.

Scholten AN, Leer JW, Collins CD, Wondergem J, Hermans J, Timothy A. Scholten AN, et al. Among authors: timothy a. Radiother Oncol. 1997 May;43(2):163-9. doi: 10.1016/s0167-8140(96)01893-2. Radiother Oncol. 1997. PMID: 9192962

2

Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases.

Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR. Nielsen OS, et al. Among authors: timothy ar. Radiother Oncol. 1998 Jun;47(3):233-40. doi: 10.1016/s0167-8140(98)00011-5. Radiother Oncol. 1998. PMID: 9681885 Clinical Trial.

3

Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma.

Sawyer EJ, Timothy AR. Sawyer EJ, et al. Among authors: timothy ar. Radiother Oncol. 1997 Jan;42(1):49-51. doi: 10.1016/s0167-8140(96)01854-3. Radiother Oncol. 1997. PMID: 9132826

4

Audit: the use of radiotherapy for NSCLC in the UK.

Maher EJ, Timothy A, Squire CJ, Goodman A, Karp SJ, Paine CH, Ryall R, Read G. Maher EJ, et al. Among authors: timothy a. Clin Oncol (R Coll Radiol). 1993;5(2):72-9. doi: 10.1016/s0936-6555(05)80850-7. Clin Oncol (R Coll Radiol). 1993. PMID: 7683203

5

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution.

Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G. Partridge S, et al. Among authors: timothy a. Ann Oncol. 2000 Oct;11(10):1273-9. doi: 10.1023/a:1008368330519. Ann Oncol. 2000. PMID: 11106116 Free article.

6

18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.

Mikhaeel NG, Timothy AR, Hain SF, O'Doherty MJ. Mikhaeel NG, et al. Among authors: timothy ar. Ann Oncol. 2000;11 Suppl 1:147-50. Ann Oncol. 2000. PMID: 10707798

7

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Hutchings M, et al. Among authors: timothy ar. Ann Oncol. 2005 Jul;16(7):1160-8. doi: 10.1093/annonc/mdi200. Epub 2005 Jun 6. Ann Oncol. 2005. PMID: 15939713 Free article. Clinical Trial.

8

Radiotherapy as salvage treatment in patients with Hodgkin's disease or non-Hodgkin's lymphoma relapsing after initial chemotherapy.

Kirkove C, Timothy AR. Kirkove C, et al. Among authors: timothy ar. Hematol Oncol. 1991 May-Jun;9(3):163-7. doi: 10.1002/hon.2900090307. Hematol Oncol. 1991. PMID: 1937407

9

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR. Mikhaeel NG, et al. Among authors: timothy ar. Ann Oncol. 2005 Sep;16(9):1514-23. doi: 10.1093/annonc/mdi272. Epub 2005 Jun 24. Ann Oncol. 2005. PMID: 15980161 Free article.

10

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.

Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN. Mikhaeel NG, et al. Among authors: timothy ar. Leuk Lymphoma. 2000 Nov;39(5-6):543-53. doi: 10.3109/10428190009113384. Leuk Lymphoma. 2000. PMID: 11342337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters